Skip to main content

Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer.

Pinhel IF, Macneill FA, Hills MJ, Salter J, Detre S, A'hern R, Nerurkar A, Osin P, Smith IE, Dowsett M

Publication: Breast Cancer Res (2010) • Vol 12 • Page R76PMID: 20920193View on PubMed

Purpose

The purpose of this paper was to determine the effects of cold ischemia time and surgical procedure type on immunohistochemical (IHC) staining in breast cancer specimens.

Conclusion

Cold ischemia times of 20-80 min had no significant effects on Ki67, estrogen receptor (ER), progesterone receptor (PR), p-Akt, p-Erk1/2, or human epidermal growth factor 2 (HER2) IHC staining when compared to core-cuts that were fixed immediately. Comparison of needle core biopsy specimens with resection specimens revealed comparable immunostaining for Ki67 and PR, a nonsignificant trend towards decreased staining for ER in resection specimens, and significantly decreased p-Akt and p-Erk1/2 staining in resection specimens. HER2 status was not influenced by the type of specimen, but specimen grades were slightly lower in resection specimens.

Studies (1)

Purpose

The purpose of this study was to determine the effects of cold ischemia time and surgical procedure type on IHC staining in breast cancer specimens.

Summary of Findings

Needle core biopsy specimens with an average room temperature cold ischemia time of 30 min (range 20-80 min) showed no significant differences in Ki67, ER, PR, p-Akt, p-Erk1/2, or HER2 IHC staining when compared to core-cuts that were fixed immediately. Comparison of needle core biopsy specimens (all cold ischemia times) with resection specimens showed comparable immunostaining for Ki67 and PR with a nonsignificant trend towards decreased staining for ER in resection specimens (p=0.06). While HER2 status was not influenced by the type of specimen, 12 of 15 specimens were graded as 1+ in the core-cut and a 0 in the resection. Significantly lower p-Akt and p-Erk1/2 immunostaining was observed in resected specimens than in core-cut specimens (p<0.0001). Interestingly, the average differences in staining were greater between core-cut and mastectomy specimens than core-cut and lumpectomy specimens, but this was only significant for p-Erk1/2 (p=0.01). Notably, mastectomy specimens were sliced prior to fixation to allow for penetration of formalin while lumpectomy specimens were left unsliced.

  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionCold ischemia time
    0 min
    20-80 min
    Biospecimen AcquisitionMethod of tissue acquisition
    Core needle biopsy
    Lumpectomy
    Mastectomy
    Surgical resection
    Immunohistochemistry SpecificTargeted peptide/protein
    ER
    HER2
    Ki67
    PR
    p-Akt
    p-Erk1/2